Avenacy, a specialty pharmaceutical company that provides essential injectable medications, has introduced a new line of injectable antibiotic products. Notably, each of the five antibiotics will feature innovative packaging and labeling designed to enhance accuracy in medication selection.

In the coming weeks, Avenacy will begin distributing the full range of antibiotics to its wholesale partners. The company’s production is backed by a global network of development and contract manufacturing partners, all of whom have successfully passed FDA inspections in compliance with cGMP standards.

“As we continue to focus on accelerating our growth, these antibiotic products will enable us to deepen our commercial presence in both the hospital and long-term/home health settings. With our growing antibiotic portfolio, we are well-positioned to drive continued market expansion that supports our long-term strategic objectives,” said Jeff Yordon, Co-Founder and CEO of Avenacy.

Image Credit: Avenacy